
### [MONDO:0007950](http://purl.obolibrary.org/obo/MONDO_0007950)
**Label:** mastocytosis

**Subclasses:** [MONDO:0015554](http://purl.obolibrary.org/obo/MONDO_0015554) (Typical urticaria pigmentosa), [MONDO:0015556](http://purl.obolibrary.org/obo/MONDO_0015556) (nodular urticaria pigmentosa), [MONDO:0019315](http://purl.obolibrary.org/obo/MONDO_0019315) (diffuse cutaneous mastocytosis), [MONDO:0015555](http://purl.obolibrary.org/obo/MONDO_0015555) (plaque-form urticaria pigmentosa), [MONDO:0019316](http://purl.obolibrary.org/obo/MONDO_0019316) (Maculopapular cutaneous mastocytosis), [MONDO:0015561](http://purl.obolibrary.org/obo/MONDO_0015561) (aleukemic mast cell leukemia), [MONDO:0017244](http://purl.obolibrary.org/obo/MONDO_0017244) (pseudoxanthomatous diffuse cutaneous mastocytosis), [MONDO:0015560](http://purl.obolibrary.org/obo/MONDO_0015560) (classic mast cell leukemia), [MONDO:0019314](http://purl.obolibrary.org/obo/MONDO_0019314) (cutaneous mastocytoma), [MONDO:0017243](http://purl.obolibrary.org/obo/MONDO_0017243) (bullous diffuse cutaneous mastocytosis), [MONDO:0016586](http://purl.obolibrary.org/obo/MONDO_0016586) (systemic mastocytosis), [MONDO:0019025](http://purl.obolibrary.org/obo/MONDO_0019025) (extracutaneous mastocytoma), [MONDO:0019576](http://purl.obolibrary.org/obo/MONDO_0019576) (telangiectasia macularis eruptiva perstans), [MONDO:0020331](http://purl.obolibrary.org/obo/MONDO_0020331) (indolent systemic mastocytosis), [MONDO:0019023](http://purl.obolibrary.org/obo/MONDO_0019023) (cutaneous mastocytosis), [MONDO:0020332](http://purl.obolibrary.org/obo/MONDO_0020332) (systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease), [MONDO:0019024](http://purl.obolibrary.org/obo/MONDO_0019024) (mast cell sarcoma), [MONDO:0020333](http://purl.obolibrary.org/obo/MONDO_0020333) (aggressive systemic mastocytosis), [MONDO:0020334](http://purl.obolibrary.org/obo/MONDO_0020334) (mast cell leukemia), [MONDO:0015558](http://purl.obolibrary.org/obo/MONDO_0015558) (isolated bone marrow mastocytosis), [MONDO:0015557](http://purl.obolibrary.org/obo/MONDO_0015557) (Smouldering systemic mastocytosis), [MONDO:0015559](http://purl.obolibrary.org/obo/MONDO_0015559) (Lymphoadenopathic mastocytosis with eosinophilia), 

**Corr. equiv. classes:** [Orphanet:79457](http://www.orpha.net/ORDO/Orphanet_79457), [Orphanet:158769](http://www.orpha.net/ORDO/Orphanet_158769), [Orphanet:280794](http://www.orpha.net/ORDO/Orphanet_280794), [Orphanet:158778](http://www.orpha.net/ORDO/Orphanet_158778), [Orphanet:280785](http://www.orpha.net/ORDO/Orphanet_280785), [Orphanet:158799](http://www.orpha.net/ORDO/Orphanet_158799), [Orphanet:158766](http://www.orpha.net/ORDO/Orphanet_158766), [Orphanet:158796](http://www.orpha.net/ORDO/Orphanet_158796), [Orphanet:158775](http://www.orpha.net/ORDO/Orphanet_158775), [Orphanet:158772](http://www.orpha.net/ORDO/Orphanet_158772), [Orphanet:66661](http://www.orpha.net/ORDO/Orphanet_66661), [Orphanet:66662](http://www.orpha.net/ORDO/Orphanet_66662), [Orphanet:158793](http://www.orpha.net/ORDO/Orphanet_158793), [Orphanet:2467](http://www.orpha.net/ORDO/Orphanet_2467), [Orphanet:90389](http://www.orpha.net/ORDO/Orphanet_90389), [Orphanet:98848](http://www.orpha.net/ORDO/Orphanet_98848), [Orphanet:66646](http://www.orpha.net/ORDO/Orphanet_66646), [Orphanet:98849](http://www.orpha.net/ORDO/Orphanet_98849), [Orphanet:98850](http://www.orpha.net/ORDO/Orphanet_98850), [Orphanet:98851](http://www.orpha.net/ORDO/Orphanet_98851), [Orphanet:79455](http://www.orpha.net/ORDO/Orphanet_79455), [Orphanet:79456](http://www.orpha.net/ORDO/Orphanet_79456), 

**Class expressions from DL-Learner:**

- [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 56.94%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis) 56.94%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 29.34%
- [HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue) 29.19%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 28.80%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 27.83%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 26.69%
- Thing 26.68%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 26.68%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 25.53%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 23.03%
- [HP:0008069](http://purl.obolibrary.org/obo/HP_0008069) (Neoplasm of the skin) 22.67%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 20.87%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 20.85%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 18.15%


